NCT02845934View on ClinicalTrials.gov

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

January 31, 2018

Conditions
Mucormycosis
Interventions
OTHER

blood sample

additional sampling of blood (estimated volume 6 mL for each sampling) on day of suspicion of the mucormycosis and then twice a week up to a maximum of 8 weeks.

Trial Locations (10)

25030

Centre Hospitalier Régional Universitaire, Besançon

Unknown

Centre Hospitalier Universitaire, Amiens

AP-HP_Henri-Mondor, Créteil

CHU, Dijon

HCL, Lyon

CHRU, Nancy

CHU, Nantes

AP-HP_ Necker, Paris

AP-HP_St-Louis, Paris

CHU, Strasbourg

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02845934 - Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis | Biotech Hunter | Biotech Hunter